Loading…

Sequential multiblock partial least squares discriminant analysis for assessing prostate cancer aggressiveness with multiparametric magnetic resonance imaging

In current radiology practice, multi-parametric magnetic resonance imaging (mpMRI) has recently become a key tool in diagnostic and therapeutic decisions. Although it is based on the subjective assessment of T2-weighted images, as well as perfusion-weighted and diffusion-weighted sequences, further...

Full description

Saved in:
Bibliographic Details
Published in:Chemometrics and intelligent laboratory systems 2022-07, Vol.226, p.104588, Article 104588
Main Authors: Aguado-Sarrió, E., Prats-Montalbán, J.M., Sanz-Requena, R., Duchesne, C., Ferrer, A.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In current radiology practice, multi-parametric magnetic resonance imaging (mpMRI) has recently become a key tool in diagnostic and therapeutic decisions. Although it is based on the subjective assessment of T2-weighted images, as well as perfusion-weighted and diffusion-weighted sequences, further quantitative parameters can also be derived from them for improving lesion phenotyping. Despite these parameters are usually exploited in a univariate way, ignoring the benefits of a real multivariate approach, still it is the gold standard imaging technique to assess prostate cancer location and probability of malignancy. In this paper, pharmacokinetic (perfusion) and exponential (diffusion) clinical models, as well as latent variable-based multivariate statistical models like multivariate curve resolution-alternating least squares (MCR-ALS), have been calculated and analyzed with sequential multi block-partial least squares discriminant analysis (SMB-PLS-DA) including technique-block differentiation, in order to better assess for cancer aggressiveness based on Gleason scales. The best prediction result was achieved by the ordered combination of diffusion blocks (MCR-ALS and exponential models) and normalized T2 values. The perfusion blocks did not improve the results obtained by diffusion and T2-weighted based parameters alone, so they can be removed from the SMB-PLS-DA model. •The capability of MRI clinical and MCR-ALS models have been jointly studied in order to better assess cancer aggressiveness.•SMB-PLS-DA has been employed for selecting the best sources in order to discriminate aggressiveness based on Gleason scales.•Statistical ​significant results shows that perfusion models do not provide any additional relevant information.
ISSN:0169-7439
1873-3239
DOI:10.1016/j.chemolab.2022.104588